Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 14, 2020
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
[ Mon, Sep 14th 2020
] - WOPRAI
Fri, September 11, 2020
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
[ Fri, Sep 11th 2020
] - WOPRAI
Anupam Rama Upgraded (VIR) to Hold and Decreased Target to $29 on, Sep 11th, 2020
Anupam Rama of JP Morgan, Upgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $30 to $29 on, Sep 11th, 2020.
Anupam has made no other calls on VIR in the last 4 months.
There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Anupam's Rating of Hold.
This is the rating of the analyst that currently disagrees with Anupam
- Alan Carr of "Needham" Initiated at Strong Buy and Held Target at $62 on, Thursday, August 20th, 2020
Similar Stocks and Investing Articles
[ Thu, Sep 10th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Mon, Mar 16th 2020
] - WOPRAI
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Tue, Jan 28th 2020
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Tue, Dec 02nd 2014
] - WOPRAI
[ Thu, Sep 18th 2014
] - WOPRAI
[ Mon, Oct 14th 2013
] - WOPRAI